Vanguard Capital Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$62.6M Buy
2,197,475
+37,018
+2% +$806K ﹤0.01% 1810
2026
Q1
$37.5M Buy
+2,160,457
New +$40.9M ﹤0.01% 2005

Other funds holding CDNA

Vanguard Capital Management's CDNA Position: Q2 2026 in Review

Vanguard Capital Management increased its CareDx (CDNA) stake by 1.7% in Q2 2026, buying an estimated $806K and bringing the position to 2,197,475 shares worth $62.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1810.

Vanguard Capital Management first reported a position in CDNA in Q1 2026 and has held it in 2 quarters since. 225 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Vanguard Capital Management held 2,197,475 shares of CareDx worth $62.6M as of Q2 2026.
  • Vanguard Capital Management bought 37,018 CareDx shares in Q2 2026, an estimated $806K.
  • CareDx made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #1810 holding.
  • Vanguard Capital Management first reported a position in CareDx in Q1 2026 and has held it in 2 quarters since.
  • 225 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.